In relation to inflammatory conditions such as sepsis, PPARγ agonists effectively suppress pro-inflammatory cytokine production and appear to be beneficial in alleviating organ injury and dysfunction, which has promising potential for therapeutic development. Here, PPARG is linked to Sepsis.